Abstract
Efficacy and Safety of Saroglitazar in Nonalcoholic Fatty Liver disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH): A Retrospective, Observational Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have